The U.S. Department of Veterans Affairs (VA) is launching a major research study to examine whether psilocybin—commonly known as “magic mushrooms”—is safe and effective for treating mental health conditions in veterans. The articles report that the study is focused on major depressive disorder, with the investigation also addressing post-traumatic stress disorder (PTSD). The initiative centers on evaluating both the safety profile of psilocybin and its potential therapeutic benefits for these diagnoses. All three outlets describe the announcement as part of the VA’s broader effort to assess the clinical value of psychedelics within a controlled research setting, rather than as an immediate change to standard treatment. The reports do not provide additional details such as study design, enrollment size, or timelines. Overall, the sources agree that the VA is initiating a formal study to determine whether psilocybin can meaningfully help veterans experiencing depression and PTSD while maintaining appropriate safeguards during administration and follow-up.